EGFR and head and neck squamous cell carcinoma: Other inhibitors of EGFR/ERBB1 tested for HNC treatment are dacomitinib and vandetanib. When used with radiotherapy, dacomitinib reduces tumor volume in HNSCC, while vandetanib, and cisplatin radiosensitizes tumor cells.